Major Growth Driver Identified in 2025 Cancer biologics Market: Rising Prevalence Of Chronic Diseases Fuels Growth In The Cancer Biologics Market

Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.

Cancer biologics Market Size Valuation Forecast: What Will the Market Be Worth by 2025?
Over the past few years, the cancer biologics market has experienced rapid growth. The market, which was valued at $106.2 billion in 2024, is projected to increase to $117.03 billion in 2025, exhibiting a compound annual growth rate (CAGR) of 10.2%. Factors leading to this growth in the historic period include a higher incidence of cancer, greater awareness of cancer biologics, enhanced efficacy and safety of cancer biologics, clearance of new cancer biologics, and a rise in acceptance of combination therapy.

Cancer biologics Market Size Forecast: What's the Projected Valuation by 2029?
In the coming years, the cancer biologics market is projected to experience robust growth. Its size is anticipated to reach $168.75 billion by 2029, with a compound annual growth rate (CAGR) of 9.6%. Factors contributing to growth during the forecast period include expanding indications, combination therapies, real-world evidence along with gene and cell therapies. The forecast period is also characterized by major trends such as advancements in biotechnology, personalized cancer biologics, biobetters, biosimilars, patient support services, and companion diagnostics.

View the full report here:
https://www.thebusinessresearchcompany.com/report/cancer-biologics-global-market-report

What Are the Drivers Transforming the Cancer biologics Market?
The escalation in the incidence of chronic ailments is a significant contributor to the growth of the cancer biologics market. Chronic diseases, which are long-term illnesses that adversely impact the health of individuals with disabilities, include the widespread ailment of cancer. The list of the most prevalent cancers features diseases such as breast cancer, lung and bronchus cancer, prostate cancer, colon and rectu*m cancer, melanoma of the skin, bladder cancer, non-Hodgkin lymphoma, kidney and renal pelvis cancer, endometrial cancer, leukemia, pancreatic cancer, thyroid cancer, and liver cancer. Notably, reports issued by the Centers for Disease Control and Prevention (CDC), a US-based public health agency, in February 2024 revealed a surge in the number of Americans managing multiple chronic illnesses, with 42% suffering from two or more, and 12% from as many as five or more. Therefore, the escalating incidence of chronic diseases is anticipated to propel further the growth of the cancer biologics market in the forthcoming years.

Get your free sample here:
https://www.thebusinessresearchcompany.com/sample.aspx?id=2563&type=smp

What Long-Term Trends Will Define the Future of the Cancer biologics Market?
Firms in the cancer biologics market are advancing predictive biomarkers, which guide doctors in choosing the suitable treatments for their patients, by making use of physical biomarkers to gauge the performance predictions. These biomarkers explore tumor expansion in individuals by examining the primary causative factors, considering variations in cancer etiology among patients. Furthermore, these biomarkers not only assist in early cancer diagnosis but also in determining the most economically viable treatment plan, particularly for biologics related to gene therapy.

Which Segments in the Cancer biologics Market Offer the Most Profit Potential?
The cancer biologics market covered in this report is segmented -

1) By Type: Monoclonal Antibodies, Vaccines, Cell And Gene Therapy, Other Types
2) By Application: Non-small Cell Lung Cancer, Prostate Cancer, Breast Cancer, Acute Myeloid Leukemia, Lymphoma, Multiple Myeloma, Ovarian Cancer, Colorectal Cancer, Gastric Cancers, Other Applications
3) By Distribution Channel: Hospitals, Clinics, Other Distribution Channels

Subsegments:
1) By Monoclonal Antibodies: Naked Monoclonal Antibodies, Conjugated Monoclonal Antibodies, Bispecific Monoclonal Antibodies
2) By Vaccines: Therapeutic Cancer Vaccines, Preventive Cancer Vaccines
3) By Cell And Gene Therapy: CAR T-Cell Therapy, Tumor-Infiltrating Lymphocytes (TIL) Therapy, Oncolytic Virus Therapy
4) By Other Types: Cytokines, Growth Factors, Fusion Proteins

Tailor your insights and customize the full report here:
https://www.thebusinessresearchcompany.com/customise?id=2563&type=smp

Which Firms Dominate the Cancer biologics Market by Market Share and Revenue in 2025?
Major companies operating in the cancer biologics market include AbbVie Inc., F. Hoffmann-La Roche AG, GlaxoSmithKline plc, Eli Lilly and Company, AmgenInc., Bristol-Myers Squibb Company, Johnson & Johnson, Merck & Co.Inc., Novartis AG, Pfizer Inc., Celgene Corporation, Daiichi Sankyo Company Ltd., Seagen Inc., Takeda Pharmaceutical Company Limited, Biogen Inc., Vertex Pharmaceuticals Incorporated, Incyte Corporation, Karyopharm Therapeutics Inc., Kyowa Kirin Co Ltd., Ipsen Biopharmaceuticals Inc., Bayer AG, Biocon Limited, Genentech Inc., Gilead Sciences Inc., Puma Biotechnology, Regeneron Pharmaceuticals Inc.

Which Regions Offer the Highest Growth Potential in the Cancer biologics Market?
The countries covered in the cancer biologics market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Italy, Spain, Canada.

Purchase the full report today:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=2563

"This Report Supports:
1.Business Leaders & Investors - To identify growth opportunities, assess risks, and guide strategic decisions.
2.Manufacturers & Suppliers - To understand market trends, customer demand, and competitive positioning.
3.Policy Makers & Regulators - To track industry developments and align regulatory frameworks.
4.Consultants & Analysts - To support market entry, expansion strategies, and client advisory work."

Connect with us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ.

Contact Us
Europe: +44 7882 955267,
Asia: +91 88972 63534,
Americas: +1 310-496-7795 or
Email: mailto:info@tbrc.info

Learn More About The Business Research Company
With over 15,000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Our flagship product, the Global Market Model delivers comprehensive and updated forecasts to support informed decision-making.

This release was published on openPR.